STAAR Surgical Company (STAA) News

STAAR Surgical Company (STAA): $142.55

-4.81 (-3.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter STAA News Items

STAA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest STAA News From Around the Web

Below are the latest news stories about Staar Surgical Co that investors may wish to consider to help them evaluate STAA as an investment opportunity.

Why Staar Surgical (STAA) Might be Well Poised for a Surge

Staar Surgical (STAA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Yahoo | August 19, 2021

STAAR Surgical Can See Its Way Higher

In the daily bar chart of STAA, below, we can see that the shares have tripled over the past 12 months. The On-Balance-Volume (OBV) is positive but shows a small dip in July suggesting some profit-taking. In this weekly Japanese candlestick chart of STAA, below, we can see the past three years of price history.

Yahoo | August 18, 2021

These 10 Standout Stocks Could Be the Next Amazon

Companies like Amazon or Visa that can generate double-digit compound growth in revenue and earnings, year after year, are rarities. These smaller candidates could do just that.

Yahoo | August 16, 2021

Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Yahoo | August 13, 2021

STAA Crosses Above Common Analyst Goal

In latest buying and selling, shares of Staar Surgical Co. (Image: STAA) have crossed above the common analyst 12-month goal value of $150.00, altering palms for $155.05/share. When a inventory reaches the goal an analyst has set, the analyst logically has two methods to react: downgrade on valuation, or, re-adjust their goal value to a [] The post STAA Crosses Above Common Analyst Goal appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

FXNews24 | August 6, 2021

Staar Surgical Stock Scores Relative Strength Rating Upgrade

Staar Surgical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investor''s Business Daily | August 6, 2021

STAAR Surgical Company (STAA) Q2 2021 Earnings Call Transcript

Thank you for joining us on the STAAR Surgical conference call this afternoon to discuss the company's financial results for the second quarter ended July 2, 2021. On the call today are Caren Mason, President and Chief Executive Officer; and Patrick Williams, Chief Financial Officer.

Yahoo | August 5, 2021

STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 2, 2021. Second Quarter 2021 Overview Record Quarterly Net Sales of $62.4 Million Up 77% from the Prior Year Quarter Record Quarterly ICL Sales of $59.2 Million Up 93% from the Prior Year Quarter Record Quarterly ICL Units, Up 79% from the Pr

Business Wire | August 4, 2021

Staar Surgical (STAA) Tops Q2 Earnings and Revenue Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of 237.50% and 17.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 4, 2021

Staar Surgical (STAA) Earnings Expected to Grow: Should You Buy?

Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 28, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5965 seconds.